Metabolic Complications in Adrenal Insufficiency.

Abstract

Pharmacological glucocorticoid treatment is associated with adverse metabolic consequences such as hypertension, overweight, reduced glucose tolerance, diabetes mellitus and ultimately increased mortality in cardiovascular disease. Here we review the evidence of detrimental effects of hormone replacement therapy in adrenal insufficiency (AI). Registry studies indicate increased cardiovascular mortality, hypertension, diabetes, and dyslipidemia in both primary and secondary AI, but when cohorts with carefully characterized patients are studied the picture is less clear, and recently patients with primary AI was reported to have less hypertension and lower body mass index than controls. Whether near physiological replacement therapy increase long-term cardiovascular morbidity and mortality in AI is still unclear.

• Authors: Grethe A Ueland, Eystein S Husebye
• Journal: Frontiers of hormone research (Front Horm Res) Vol. 49 Pg. 104-113 ( 2018) ISSN: 1662-3762 [Electronic] Switzerland
• PMID: 29894991 (Publication Type: Journal Article, Review)
• Copyright: © 2018 S. Karger AG, Basel.

Chemical References

• Glucocorticoids

Topics

• Adrenal Insufficiency (drug therapy)
• Cardiovascular Diseases (chemically induced, etiology)
• Diabetes Mellitus (chemically induced, etiology)
• Dyslipidemias (chemically induced, etiology)
• Glucocorticoids (adverse effects)
• Hormone Replacement Therapy (adverse effects)
• Humans
• Hypertension (chemically induced, etiology)